Tenaya Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tenaya Therapeutics generated cash of -$102,072,000, which is more than the previous year. Cash used in financing activities reached the amount of $4,049,000 last year. Net change in cash is therefore -$49,308,000.
Cash Flow
| 2019 | -24.09M | -5.58M | 30.51M |
|---|---|---|---|
| 2020 | -35.44M | -7.01M | 147.26M |
| 2021 | -60.81M | -238.56M | 208.97M |
| 2022 | -104.42M | 83.65M | 77.76M |
| 2023 | -102.07M | 48.71M | 4.04M |
TNYA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 95.67M | 38.67M | 129.08M | 24.27M | 23.43M |
Operating activities | |||||
Net income | -124.08M | -123.66M | -72.72M | -38.39M | -26.23M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 8.68M | 6.46M | 2.96M | 2.48M | 1.98M |
Stock-based compensation expense | 15.30M | 11.46M | 2.95M | 741K | 414K |
| Deferred income tax benefit | 15.30M | 11.46M | 2.95M | 741K | 414K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -3.28M | 1.66M | 8.6M | 142K | 397K |
Cash generated by operating activities | -102.07M | -104.42M | -60.81M | -35.44M | -24.09M |
Investing activities | |||||
Purchases Of Investments | -56.64M | -140.47M | -213.44M | 0 | -12.65M |
Investments In Property Plant And Equipment | -1.23M | -20.63M | -25.12M | -9.76M | -2.92M |
Acquisitions Net | 0 | 0 | 0 | 0 | 2.65K |
Cash generated by investing activities | 48.71M | 83.65M | -238.56M | -7.01M | -5.58M |
Financing activities | |||||
Common Stock Issued | 3.86M | 77.38M | 188.54M | 147.26M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -13K | -1K | -3K |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 4.04M | 77.76M | 208.97M | 147.26M | 30.51M |
Net Change In Cash | -49.30M | 56.99M | -90.40M | 104.81M | 832K |
Cash at end of period | 46.36M | 95.67M | 38.67M | 129.08M | 24.27M |
| Data source | Data source | Data source |